menu
    • menu

    Company profile for CuraTeQ Biologics

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma Ltd., is an EU GMP certified biopharmaceutical company based in Hyderabad, India. The company focuses on developing and manufacturing biosimilars and vaccines, with a leadership team comprising scientific experts in the field. CuraTeQ is committed to creating a sustainable and broad portfolio of biosimilars, particularly in oncology and immunology, aiming to prov...
    CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma Ltd., is an EU GMP certified biopharmaceutical company based in Hyderabad, India. The company focuses on developing and manufacturing biosimilars and vaccines, with a leadership team comprising scientific experts in the field. CuraTeQ is committed to creating a sustainable and broad portfolio of biosimilars, particularly in oncology and immunology, aiming to provide affordable and effective treatments for a range of serious diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CuraTeQ Biologicsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Galaxy Towers, Floors: 22-24, Plot No. 1, Survey No. 83/1, Hyderabad Knowled...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://curateqbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurobindo Pharma's Curateq Receives Health Canada Approval
    Aurobindo Pharma's Curateq Receives Health Canada Approval

    01 May 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-arm-curateq-gets-health-canada-nod-for-biosimilar/articleshow/130674395.cms

    ECONOMICTIMES
    01 May 2026
    Share Share
    Curateq Biologics Reports Phase 3 Results for BP11
    Curateq Biologics Reports Phase 3 Results for BP11

    07 Apr 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/curateq-biologics-reports-phase-3-results-for-bp11-biosimilar-to-xolair/

    EXPRESSPHARMA
    07 Apr 2026
    Share Share
    CuraTeQ Bio Enters Into Agreement with Stada Arzneimittel AG
    CuraTeQ Bio Enters Into Agreement with Stada Arzneimittel AG

    27 Mar 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/curateq-biologics-enters-into-agreement-with-stada-arzneimittel-ag-19469

    INDPHARMAPOST
    27 Mar 2026
    Share Share
    Aurobindo Pharma's Dyrupeg Faces Health Canada Compliance Notice
    Aurobindo Pharma's Dyrupeg Faces Health Canada Compliance Notice

    09 Jan 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharmas-dyrupeg-faces-health-canada-compliance-notice/articleshow/126435665.cms

    ECONOMICTIMES
    09 Jan 2026
    Share Share
    CuraTeQ Bio Completes Ph 3 Study for Denosumab Biosimilar
    CuraTeQ Bio Completes Ph 3 Study for Denosumab Biosimilar

    19 Sep 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/curateq-biologics-completes-phase-3-clinical-study-for-denosumab-biosimilar-17842

    INDPHARMAPOST
    19 Sep 2025
    Share Share
    Aurobindo's Unit Receive UK Approval for Biosimilar Breast Cancer
    Aurobindo's Unit Receive UK Approval for Biosimilar Breast Cancer

    27 Aug 2025

    // BUSINESS STD

    https://www.business-standard.com/industry/news/aurobindo-pharma-subsidiary-uk-approval-breast-cancer-drug-dazublys-125082601330_1.html

    BUSINESS STD
    27 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search